Electronic cigarettes: A position statement from the Thoracic Society of Australia and New Zealand*

Respirology

Volumn 25, Issue 10, 2020, Pages 1082-1089

  McDonald, Christine F ^a,b,c   Jones, Stuart ^d   Beckert, Lutz ^e   Bonevski, Billie ^f   Buchanan, Tanya ^g   Bozier, Jack ^h,i   Carson Chahhoud, Kristin V ^j,k,l   Chapman, David G ^h,i   Dobler, Claudia C ^m,n   Foster, Juliet M ⁱ   Hamor, Paul ^o,p   Hodge, Sandra ^l,q   Holmes, Peter W ^r   Larcombe, Alexander N ^s,t   Marshall, Henry M ^u,v   McCallum, Gabrielle B ^w   Miller, Alistair ^x,y   Pattemore, Philip ^e   Roseby, Robert ^z,aa   See, Hayley V ^f,ab   Stone, Emily ^ac   Thompson, Bruce R ^ad   Ween, Miranda P ^l,q   Peters, Matthew J ^ae,af,ag   more..

^a AUSTIN HEALTH   (Australia)

^b INSTITUTE FOR BREATHING AND SLEEP   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d MIDDLEMORE HOSPITAL   (New Zealand)

^e UNIVERSITY OF OTAGO   (New Zealand)

^f UNIVERSITY OF NEWCASTLE   (Australia)

^g UNIVERSITY OF WOLLONGONG   (Australia)

^h UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

ⁱ UNIVERSITY OF SYDNEY   (Australia)

^j Australian Centre for Precision Health   (Australia)

^k UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^l UNIVERSITY OF ADELAIDE   (Australia)

^m GOLD COAST UNIVERSITY HOSPITAL   (Australia)

ⁿ LIVERPOOL HOSPITAL   (Australia)

^o PRINCE OF WALES HOSPITAL   (Australia)

^p UNIVERSITY OF NEW SOUTH WALES   (Australia)

^q ROYAL ADELAIDE HOSPITAL   (Australia)

^r MONASH MEDICAL CENTRE   (Australia)

^s UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^t CURTIN UNIVERSITY   (Australia)

^u THE PRINCE CHARLES HOSPITAL   (Australia)

^v UNIVERSITY OF QUEENSLAND   (Australia)

^w MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^x ROYAL MELBOURNE HOSPITAL   (Australia)

^y PETER MACCALLUM CANCER CENTRE   (Australia)

^z MONASH CHILDREN S HOSPITAL   (Australia)

^aa MONASH UNIVERSITY   (Australia)

^ab HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

^ac ST VINCENT S HOSPITAL   (Australia)

^ad SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

^ae Department of Microbiology and Infectious Diseases   (Australia)

^af University of Sydney   (Australia)

^ag MACQUARIE UNIVERSITY   (Australia)

more..

Author keywords

e cigarettes; public health; smoking cessation; tobacco control; vaping

Indexed keywords

AUSTRALIA AND NEW ZEALAND; CONSUMER; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; EX-SMOKER; HUMAN; JUVENILE; LUNG; PRACTICE GUIDELINE; PUBLIC HEALTH; REVIEW; SMOKING CESSATION; SYSTEMATIC REVIEW; UNITED STATES; VAPING; ADOLESCENT; ADULT; ADVERSE EVENT; AUSTRALIA; ELECTRONIC CIGARETTE; FEMALE; MALE; MEDICAL SOCIETY; NEW ZEALAND; RISK FACTOR; SMOKING;

ADOLESCENT; ADULT; AUSTRALIA; ELECTRONIC NICOTINE DELIVERY SYSTEMS; FEMALE; HUMANS; MALE; NEW ZEALAND; PUBLIC HEALTH; RISK FACTORS; SMOKING; SMOKING CESSATION; SOCIETIES, MEDICAL; TOBACCO SMOKING; UNITED STATES;

EID: 85088456002     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.13904     Document Type: Review

References (71)

1. Australian Government Department of Health. Non-nicotine liquids for e-cigarette devices in Australia: chemistry and health concerns. 2019. National Industrial Chemicals Notification and Assessment Scheme. Available from URL: https://www.industrialchemicals.gov.au/consumers-and-community/e-cigarettes-and-personal-vaporisers
2. Australian Government Department of Health. Evaluation of effectiveness of graphic health warnings on tobacco product packaging. An Evaluation Report [Internet]. Canberra. 2018. [Accessed 8 May 2020.] Available from URL: https://www.health.gov.au/resources/publications/evaluation-of-effectiveness-of-graphic-health-warnings-on-tobacco-product-packaging
3. Australian Institute of Health and Welfare. Alcohol, tobacco & other drugs in Australia [Internet]. Canberra: Australian Institute of Health and Welfare. 2020. [Accessed 8 May 2020.] Available from URL: https://www.aihw.gov.au/reports/alcohol/alcohol-tobacco-other-drugs-australia
4. Greenhalgh EM, Grace C. Tobacco advertising and promotion. In: Scollo MM, Winstanley MH (eds) Tobacco in Australia: Facts and Issues. Melbourne, Cancer Council Victoria, 2016. Available from URL https://www.tobaccoinaustralia.org.au/chapter-11-advertising.
5. Greenhalgh EM, Stillman S, Ford C. 7.6 How smokers go about quitting. In: Scollo MM, Winstanley MH (eds) Tobacco in Australia: Facts and Issues. Melbourne, Cancer Council Victoria, 2018. Available from http://www.tobaccoinaustralia.org.au/7-3-the-process-of-quitting.
6. Greenhalgh EM, Scollo M, Winstanley MH. 1.3 Prevalence of smoking—adults. In: Tobacco in Australia: Facts and issues, 1st edn. Melbourne, Cancer Council Victoria, 2019.
7. Health Promotion Agency. Smokefree New Zealand: Facts and Figures. 2019. [Accessed 30 Jan 2020.] Available from URL: https://www.smokefree.org.nz/smoking-its-effects/facts-figures
8. New Zealand Ministry of Health. Smokefree Aotearoa 2025 Health Effects of Smoking [Internet]. 2020. [Accessed May 2020.] Available from URL: https://www.health.govt.nz/our-work/preventative-health-wellness/tobacco-control/smokefree-aotearoa-2025
9. Greenhalgh EM, Scollo M, Winstanley MH. 1.6 Prevalence of smoking—teenagers. In: Tobacco in Australia: Facts and Issues, 1st edn. Melbourne, Cancer Council Victoria, 2019. Available from URL: http://www.tobaccoinaustralia.org.au.
10. Banks E, Joshy G, Weber M, Liu B, Grenfell R, Egger S, Paige E, Lopez AD, Sitas F, Beral V. Tobacco smoking and all-cause mortality in a large Australian cohort study: findings from a mature epidemic with current low smoking prevalence. BMC Med. 2015; 13: 38.
11. Whetton S, Tait R, Scollo M, Banks E, Chapman J, Dey T, Halim SA, Makate M, McEntee A, Muhktar A et al. Identifying the Social Costs of Tobacco Use to Australia in 2015/16. Perth, Australia, National Drug Research Institute, 2019.
12. New Zealand Ministry of Health. Health effects of smoking [Internet]. [Accessed February 2 2019.] Available from URL: https://www.health.govt.nz/your-health/healthy-living/addictions/smoking/health-effects-smoking.
13. Australian Institute of Health and Welfare. Burden of tobacco use in Australia: Australian Burden of Disease Study 2015. Australian Burden of Disease Series No. 21. Cat. No. BOD 20. Canberra: AIHW, 2019.
14. McNeill A, Brose LS, Calder R, Bauld L, Robson D. Evidence Review of E-Cigarettes and Heated Tobacco Products. London, Public Health England, 2018.
15. National Academies of Sciences, Engineering, and Medicine. Public Health Consequences of E-Cigarettes. Washington, DC, The National Academies Press, 2018.
16. Byrne S, Brindal E, Williams G, Anastasiou K, Tonkin A, Battams S, Riley M. E-Cigarettes, Smoking and Health. A Literature Review Update. Canberra, CSIRO, 2018.
17. Institute for Global Tobacco Control. Country Laws Regulating E-Cigarettes: A Policy Scan. Baltimore, MD: Johns Hopkins Bloomberg School of Public Health. [Accessed May 18 2020.] Available from URL: https://www.globaltobaccocontrol.org/e-cigarette_policyscan
18. Ghosh A, Coakley R, Mascenik T, Rowell T, Davis E, Rogers K, Webster MJ, Dang H, Herring LE, Sassano MF et al. Chronic E-cigarette exposure alters the human bronchial epithelial proteome. Am. J. Respir. Crit. Care Med. 2018; 198: 67–76.
19. Chaumont M, Bernard A, Pochet S, Melot C, El Khattabi C, Reye F, Boudjeltia K, Van Antwerpen P, Delporte C, van de Borne P. High-wattage E-cigarettes induce tissue hypoxia and lower airway injury: a randomized clinical trial. Am. J. Respir. Crit. Care Med. 2018; 198: 123–6.
20. Clapp P, Pawlak E, Lackey J, Keating J, Reeber S, Glish G, Jaspers I. Flavored e-cigarette liquids and cinnamaldehyde impair respiratory innate immune cell function. Am. J. Physiol. Lung Cell. Mol. Physiol. 2017; 313: L278–92.
21. Sherwood CL, Boitano S. Airway epithelial cell exposure to distinct e-cigarette liquid flavorings reveals toxicity thresholds and activation of CFTR by the chocolate flavoring 2,5-dimethylpyrazine. Respir. Res. 2016; 17: 57.
22. St Helen G, Dempsey D, Havel C, Jacob P, Benowitz N. Impact of e-liquid flavors on nicotine intake and pharmacology of e-cigarettes. Drug Alcohol Depend. 2017; 178: 391–8.
23. Flacco M, Ferrante M, Fiore M, Marzuillo C, La Vecchia C, Gualano M, Liguori G, Fragassi G, Carradori T, Bravi F et al. Cohort study of electronic cigarette use: safety and effectiveness after 4 years of follow-up. Eur. Rev. Med. Pharmacol. Sci. 2019; 23: 402–12.
24. U.S. Department of Health and Human Services. Smoking cessation. A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2020.
25. Mowry J, Spyker D, Brooks D, Zimmerman A, Schauben J. 2015 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 33rd Annual Report. Clin. Toxicol. (Phila.) 2016; 54: 924–1109.
26. Richmond SA, Pike I, Maguire JL, Macpherson A. E-cigarettes: a new hazard for children and adolescents. Paediatr. Child Health 2018; 23: 255–9.
27. Al-Aali KA, Airabiah M, ArRejaie AS, Abduljabbar T, Vohra F, Akram Z. Peri-implant parameters, tumor necrosis factor-alpha, and interleukin-1 beta levels in vaping individuals. Clin. Implant Dent. Relat. Res. 2018; 20: 410–5.
28. Toy J, Dong F, Lee C, Zappa D, Le T, Archambeau B, Culhane J, Neeki M. Alarming increase in electronic nicotine delivery systems-related burn injuries: a serious unregulated public health issue. Am. J. Emerg. Med. 2017; 35: 1781–2.
29. Hickey S, Goverman J, Friedstat J, Sheridan R, Schulz J. Thermal injuries from exploding electronic cigarettes. Burns 2018; 44: 1294–301.
30. Corey CG, Chang JT, Rostron BL. Electronic nicotine delivery system (ENDS) battery-related burns presenting to US emergency departments. Inj. Epidemiol. 2016; 5: 4.
31. National Health and Medical Research Council. CEO Statement: Electronic Cigarettes. 2017. [Accessed May 2020.] Available from URL: https://www.nhmrc.gov.au/about-us/resources/ceo-statement-electronic-cigarettes
32. Bals R, Boyd J, Esposito S, Foronjy R, Hiemstra P, Jiménez-Ruiz C, Katsaounou P, Lindberg A, Metz C, Schober W et al. Electronic cigarettes: a task force report from the European Respiratory Society. Eur. Respir. J. 2019; 53: 1801151.
33. Masiero M, Lucchiari C, Mazzocco K, Veronesi G, Maisonneuve P, Jemos C, Salè E, Spina S, Bertolotti R, Pravettoni G. E-cigarettes may support smokers with high smoking-related risk awareness to stop smoking in the short run: preliminary results by randomized controlled trial. Nicotine Tob. Res. 2019; 21: 119–26.
34. Baldassarri SR, Bernstein SL, Chupp GL, Slade MD, Fucito LM, Toll BA. Electronic cigarettes for adults with tobacco dependence enrolled in a tobacco treatment program: a pilot study. Addict. Behav. 2018; 80: 1–5.
35. Halpern S, Harhay M, Saulsgiver K, Brophy C, Troxel A, Volpp K. A pragmatic trial of E-cigarettes, incentives, and drugs for smoking cessation. N. Engl. J. Med. 2018; 378: 2302–10.
36. Carpenter MJ, Heckman BW, Wahlquist AE, Wagener TL, Goniewicz ML, Gray KM, Froeliger B, Cummings KM. A naturalistic, randomized pilot trial of E-cigarettes: uptake, exposure, and behavioral effects. Cancer Epidemiol. Biomarkers Prev. 2017; 26: 1795–803.
37. Meier E, Wahlquist A, Heckman B, Cummings K, Froeliger B, Carpenter M. A pilot randomized crossover trial of electronic cigarette sampling among smokers. Nicotine Tob. Res. 2017; 19: 176–82.
38. Hajek P, Phillips-Waller A, Przulj D, Pesola F, Myers Smith K, Bisal N, Li J, Parrott S, Sasieni P, Dawkins L et al. A randomized trial of E-cigarettes versus nicotine-replacement therapy. N. Engl. J. Med. 2019; 380: 629–37.
39. Beard E, Brown J, Michie S, West R. Is prevalence of e-cigarette and nicotine replacement therapy use among smokers associated with average cigarette consumption in England? A time-series analysis. BMJ Open 2018; 8: e016046.
40. Greenhalgh EM, Stillman S, Ford C. 7.6 How smokers go about quitting. In: Scollo MM, Winstanley MH (eds) Tobacco in Australia: Facts and Issues. Melbourne, Cancer Council Victoria, 2016. Available from URL: http://www.tobaccoinaustralia.org.au.
41. The Royal Australian College of General Practitioners. Supporting Smoking Cessation: A Guide for Health Professionals, 2nd edn. Melbourne, RACGP, 2019.
42. Ministry of Health. The New Zealand Guidelines for Helping People to Stop Smoking. Wellington: Ministry of Health. 2014. [Accessed May 2020.] Available from URL: https://www.health.govt.nz/publication/new-zealand-guidelines-helping-people-stop-smoking
43. Ferkol TW, Farber HJ, La Grutta S, Leone FT, Marshall HM, Neptune E, Pisinger C, Vanker A, Wisotzky M, Zabert GE et al. Electronic cigarette use in youths: a position statement of the Forum of International Respiratory Societies. Eur. Respir. J. 2018; 51: 1800278.
44. U.S. Department of Health and Human Services. E-cigarette use among youth and young adults. A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2016.
45. Warner KE, Mendez D. E-cigarettes: comparing the possible risks of increasing smoking initiation with the potential benefits of increasing smoking cessation. Nicotine Tob. Res. 2019; 21: 41–7.
46. Warner K. How to think – not feel – about tobacco harm reduction. Nicotine Tob. Res. 2018; 21: 1299–309.
47. Levy DT, Borland R, Lindblom EN, Goniewicz ML, Meza R, Holford TR, Yuan Z, Luo Y, O'Connor RJ, Niaura R et al. Potential deaths averted in USA by replacing cigarettes with e-cigarettes. Tob. Control 2018; 27: 18–25.
48. Gao W, Sanna M, Huang LL, Chiu YW, Chen YH, Chiou HY. Juggling two balls-smoking (re)normalization and harm reduction: e-cigarettes-facts and misconceptions in Taiwan. Asia Pac. J. Public Health 2018; 30: 328–31.
49. Miech R, Patrick ME, O'Malley PM, Johnston LD. What are kids vaping? Results from a national survey of US adolescents. Tob. Control 2017; 24: 386–91.
50. Dutra LM, Glantz SA. E-cigarettes and national adolescent cigarette use: 2004-2014. Pediatrics 2017; 139: e20162450.
51. Etter JF. Gateway effects and electronic cigarettes. Addiction 2018; 113: 1776–83.
52. Gentry S, Fourouhi NG, Notley C. Are electronic cigarettes an effective aid to smoking cessation or reduction among vulnerable groups? A systematic review of quantitative and qualitative evidence. Nicotine Tob. Res. 2018; 21: 606–16.
53. Caponnetto P, Auditore R, Russo C, Cappello GC, Polosa R. Impact of an electronic cigarette on smoking reduction and cessation in schizophrenic smokers: a prospective 12-month pilot study. Int. J. Environ. Res. Public Health 2013; 10: 446–61.
54. O'Brien B, Knight-West O, Walker N, Parag V, Bullen C. E-cigarettes versus NRT for smoking reduction or cessation in people with mental illness: secondary analysis of data from the ASCEND trial. Tob. Induc. Dis. 2015; 13: 5.
55. Stein MD, Caviness C, Grimone K, Audet D, Anderson BJ, Bailey GL. An open trial of electronic cigarettes for smoking cessation among methadone-maintained smokers. Nicotine Tob. Res. 2016; 18: 1157–62.
56. Truman P, Gilmour M, Robinson G. Acceptability of electronic cigarettes as an option to replace tobacco smoking for alcoholics admitted to hospital for detoxification. N. Z. Med. J. 2018; 131: 22–8.
57. Valentine G, Hefner K, Jatlow P, Rosenheck R, Gueorguieva R, Sofuoglu M. Impact of e-cigarettes on smoking and related outcomes in veteran smokers with psychiatric comorbidity. J. Dual Diagn. 2018; 14: 2–13.
58. Hickling L, Perez-Iglesias R, McNeill A, Dawkins L, Moxham J, Ruffell T, Sendt K, McGuire P. A pre-post pilot study of electronic cigarettes to reduce smoking in people with severe mental illness. Psychol. Med. 2019; 49: 1033–40.
59. Siu AL, U.S. Preventative Services Task Force. Behavioral and pharmacotherapy interventions for tobacco smoking cessation in adults, including pregnant women: U.S. Preventive Services Task Force recommendation statement. Ann. Intern. Med. 2015; 163: 622–34.
60. Meurk C, Ford P, Sharma R, Fitzgerald L, Gartner C. Views and preferences for nicotine products as an alternative to smoking: a focus group study of people living with mental disorders. Int. J. Environ. Res. Public Health 2016; 13: 1166.
61. Tucker MR, Kivell BM, Laugesen M, Grace RC. Changes to smoking habits and addiction following tobacco excise tax increases: a comparison of Māori, Pacific and New Zealand European smokers. Aust. N. Z. J. Public Health 2017; 41: 92–8.
62. Bowker K, Orton S, Cooper S, Naughton F, Whitemore R, Lewis S, Bauld L, Sinclair L, Coleman T, Dickinson A et al. Views on and experiences of electronic cigarettes: a qualitative study of women who are pregnant or have recently given birth. BMC Pregnancy Childbirth 2018; 18: 233.
63. Wigginton B, Gartner C, Rowlands IJ. Is it safe to vape? Analyzing online forums discussing e-cigarette use during pregnancy. Womens Health Issues 2017; 27: 93–9.
64. Bhandari N, Day K, Payakachat N, Franks A, McCain K, Ragland D. Use and risk perception of electronic nicotine delivery systems and tobacco in pregnancy. Womens Health Issues 2018; 28: 251–7.
65. McCubbin A, Fallin-Bennett A, Barnett J, Ashford K. Perceptions and use of electronic cigarettes in pregnancy. Health Educ. Res. 2017; 32: 22–32.
66. Prochaska JJ, Grana RA. E-cigarette use among smokers with serious mental illness. PLoS One. 2014; 9: e113013.
67. Spears CA, Jones D, Weaver SR, Pechacek TF, Eriksen MP. Use of electronic nicotine delivery systems among adults with mental health conditions. Int. J. Environ. Res. Public Health 2016; 14: 10.
68. Gubner NR, Pagona A, Tajima B, Guydish J. A comparison of daily versus weekly electronic cigarette users in treatment for substance abuse. Nicotine Tob. Res. 2018; 20: 636–42.
69. Stein M, Caviness C, Grimone K, Audet D, Borges A, Anderson B. E-cigarette knowledge, attitudes, and use in opioid dependent smokers. J. Subst. Abuse Treat. 2015; 52: 73–7.
70. Guydish J, Tajima B, Pramod S, Le T, Gubner NR, Campbell B, Roman P. Use of multiple tobacco products in a national sample of persons enrolled in addiction treatment. Drug Alcohol Depend. 2016; 166: 93–9.
71. Cockburn N, Gartner C, Ford PJ. Smoking behaviour and preferences for cessation support among clients of an Indigenous community-controlled health service. Drug Alcohol Rev. 2018; 37: 676–82.